The CAG Regimen (Low-dose Cytarabine, Aclarubicin Hydrochloride and Granulocyte Colony-stimulating Factor) for the Treatment of Elderly Acute Myelomonocytic Leukaemia: a Case Study

Author： Tsuda T   Okamoto Y   Sakaguchi R   Katayama N   Ota K  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.29, Iss.1, 2001-01, pp. : 41-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Granulocyte colony-stimulating factors: Acute myeloid leukaemia?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1223, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Antineoplastics/pirarubicin: Acute myeloid leukaemia in elderly patients, treated with cytarabine, aclarubicin and G-CSF: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Combining fludarabine, cytarabine [Ara-C], idarubicin plus granulocyte colony-stimulating factor (G-CSF) is effective for refractory acute leukaemias

By  

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) does not appear to have any additional benefit in patients with acute myeloid leukaemia (AML) receiving chemotherapy

By  

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factors: Rheumatoid vasculitis in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1168, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite